Organizational correlates of adolescent immunization: Findings of a state-wide study of primary care clinics in North Carolina

Jennifer Moss, Melissa B. Gilkey, Turquoise Griffith, J. Michael Bowling, Amanda M. Dayton, Amy H. Grimshaw, Beth Quinn, Noel T. Brewer

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: To analyze organizational correlates of immunization coverage among adolescents served by high-volume primary care providers in North Carolina. Methods: We randomly selected 91 clinics with at least 200 active records for patients ages 11-18 in the North Carolina Immunization Registry. For the 105,121 adolescents served by these clinics, we obtained immunization status for 6 vaccines, including human papillomavirus (HPV) vaccine (females only); meningococcal conjugate; and tetanus, diphtheria, and pertussis booster (Tdap). Results: Clinics specializing in pediatrics had higher coverage for meningococcal vaccine (OR. = 1.79, 95% CI: 1.25-2.55), Tdap vaccine (OR. = 1.22, 95% CI: 1.00-1.50), and childhood vaccines. However, pediatric clinics had lower coverage for HPV vaccine initiation (OR. = 0.70, 95% CI: 0.52-0.94). Other correlates, which varied by vaccine, included policies related to vaccine documentation and the age at which clinics recommended vaccines. Conclusion: Overall, adolescents were more likely to receive vaccines, except HPV vaccine, if they attended a pediatric clinic with supportive clinical policies.

Original languageEnglish (US)
Pages (from-to)4436-4441
Number of pages6
JournalVaccine
Volume31
Issue number40
DOIs
StatePublished - Sep 13 2013

Fingerprint

Immunization
Primary Health Care
immunization
Vaccines
vaccines
Papillomavirus Vaccines
Pediatrics
Papillomaviridae
Diphtheria-Tetanus-Pertussis Vaccine
Meningococcal Vaccines
whooping cough
tetanus
Diphtheria
Whooping Cough
Tetanus
Documentation
Registries
childhood

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Moss, J., Gilkey, M. B., Griffith, T., Bowling, J. M., Dayton, A. M., Grimshaw, A. H., ... Brewer, N. T. (2013). Organizational correlates of adolescent immunization: Findings of a state-wide study of primary care clinics in North Carolina. Vaccine, 31(40), 4436-4441. https://doi.org/10.1016/j.vaccine.2013.06.092
Moss, Jennifer ; Gilkey, Melissa B. ; Griffith, Turquoise ; Bowling, J. Michael ; Dayton, Amanda M. ; Grimshaw, Amy H. ; Quinn, Beth ; Brewer, Noel T. / Organizational correlates of adolescent immunization : Findings of a state-wide study of primary care clinics in North Carolina. In: Vaccine. 2013 ; Vol. 31, No. 40. pp. 4436-4441.
@article{3424eac91d2f48b88a2f10652c811190,
title = "Organizational correlates of adolescent immunization: Findings of a state-wide study of primary care clinics in North Carolina",
abstract = "Objective: To analyze organizational correlates of immunization coverage among adolescents served by high-volume primary care providers in North Carolina. Methods: We randomly selected 91 clinics with at least 200 active records for patients ages 11-18 in the North Carolina Immunization Registry. For the 105,121 adolescents served by these clinics, we obtained immunization status for 6 vaccines, including human papillomavirus (HPV) vaccine (females only); meningococcal conjugate; and tetanus, diphtheria, and pertussis booster (Tdap). Results: Clinics specializing in pediatrics had higher coverage for meningococcal vaccine (OR. = 1.79, 95{\%} CI: 1.25-2.55), Tdap vaccine (OR. = 1.22, 95{\%} CI: 1.00-1.50), and childhood vaccines. However, pediatric clinics had lower coverage for HPV vaccine initiation (OR. = 0.70, 95{\%} CI: 0.52-0.94). Other correlates, which varied by vaccine, included policies related to vaccine documentation and the age at which clinics recommended vaccines. Conclusion: Overall, adolescents were more likely to receive vaccines, except HPV vaccine, if they attended a pediatric clinic with supportive clinical policies.",
author = "Jennifer Moss and Gilkey, {Melissa B.} and Turquoise Griffith and Bowling, {J. Michael} and Dayton, {Amanda M.} and Grimshaw, {Amy H.} and Beth Quinn and Brewer, {Noel T.}",
year = "2013",
month = "9",
day = "13",
doi = "10.1016/j.vaccine.2013.06.092",
language = "English (US)",
volume = "31",
pages = "4436--4441",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "40",

}

Moss, J, Gilkey, MB, Griffith, T, Bowling, JM, Dayton, AM, Grimshaw, AH, Quinn, B & Brewer, NT 2013, 'Organizational correlates of adolescent immunization: Findings of a state-wide study of primary care clinics in North Carolina', Vaccine, vol. 31, no. 40, pp. 4436-4441. https://doi.org/10.1016/j.vaccine.2013.06.092

Organizational correlates of adolescent immunization : Findings of a state-wide study of primary care clinics in North Carolina. / Moss, Jennifer; Gilkey, Melissa B.; Griffith, Turquoise; Bowling, J. Michael; Dayton, Amanda M.; Grimshaw, Amy H.; Quinn, Beth; Brewer, Noel T.

In: Vaccine, Vol. 31, No. 40, 13.09.2013, p. 4436-4441.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Organizational correlates of adolescent immunization

T2 - Findings of a state-wide study of primary care clinics in North Carolina

AU - Moss, Jennifer

AU - Gilkey, Melissa B.

AU - Griffith, Turquoise

AU - Bowling, J. Michael

AU - Dayton, Amanda M.

AU - Grimshaw, Amy H.

AU - Quinn, Beth

AU - Brewer, Noel T.

PY - 2013/9/13

Y1 - 2013/9/13

N2 - Objective: To analyze organizational correlates of immunization coverage among adolescents served by high-volume primary care providers in North Carolina. Methods: We randomly selected 91 clinics with at least 200 active records for patients ages 11-18 in the North Carolina Immunization Registry. For the 105,121 adolescents served by these clinics, we obtained immunization status for 6 vaccines, including human papillomavirus (HPV) vaccine (females only); meningococcal conjugate; and tetanus, diphtheria, and pertussis booster (Tdap). Results: Clinics specializing in pediatrics had higher coverage for meningococcal vaccine (OR. = 1.79, 95% CI: 1.25-2.55), Tdap vaccine (OR. = 1.22, 95% CI: 1.00-1.50), and childhood vaccines. However, pediatric clinics had lower coverage for HPV vaccine initiation (OR. = 0.70, 95% CI: 0.52-0.94). Other correlates, which varied by vaccine, included policies related to vaccine documentation and the age at which clinics recommended vaccines. Conclusion: Overall, adolescents were more likely to receive vaccines, except HPV vaccine, if they attended a pediatric clinic with supportive clinical policies.

AB - Objective: To analyze organizational correlates of immunization coverage among adolescents served by high-volume primary care providers in North Carolina. Methods: We randomly selected 91 clinics with at least 200 active records for patients ages 11-18 in the North Carolina Immunization Registry. For the 105,121 adolescents served by these clinics, we obtained immunization status for 6 vaccines, including human papillomavirus (HPV) vaccine (females only); meningococcal conjugate; and tetanus, diphtheria, and pertussis booster (Tdap). Results: Clinics specializing in pediatrics had higher coverage for meningococcal vaccine (OR. = 1.79, 95% CI: 1.25-2.55), Tdap vaccine (OR. = 1.22, 95% CI: 1.00-1.50), and childhood vaccines. However, pediatric clinics had lower coverage for HPV vaccine initiation (OR. = 0.70, 95% CI: 0.52-0.94). Other correlates, which varied by vaccine, included policies related to vaccine documentation and the age at which clinics recommended vaccines. Conclusion: Overall, adolescents were more likely to receive vaccines, except HPV vaccine, if they attended a pediatric clinic with supportive clinical policies.

UR - http://www.scopus.com/inward/record.url?scp=84882882172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882882172&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2013.06.092

DO - 10.1016/j.vaccine.2013.06.092

M3 - Article

C2 - 23845803

AN - SCOPUS:84882882172

VL - 31

SP - 4436

EP - 4441

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 40

ER -